Stay updated with breaking news from Structural Heart Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research presented at the American Heart Association’s Scientific Sessions 2023 suggests that current recommendation for vitamin D dosage are not sufficiently high to support optimal heart health.
A single dose of an experimental medication called zilebesiran was safe and effective in lowering blood pressure for 6 month, a study finds.
A clinical trial suggests that a single infusion of a gene-editing therapeutic could help reduce high levels of hereditary LDL-C, or 'bad,' cholesterol.
Researchers report promising results in initial clinical trials on two new drugs that target high cholesterol in different ways at the genetic level
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States